Chumakov Federal Scientific Center For Research And Development Of Immune-and-biological Products

This study tested the CoviVac COVID-19 vaccine in 200 adults aged 60 and older. The goal was to see if the vaccine is safe and triggers a strong immune response. Researchers measured side effects and antibody levels after vaccination. The vaccine uses a killed virus to teach the …